Results of a multicentre survey evaluating clinical practice of port and Broviac management in paediatric oncology;Ergebnisse eines multizentrischen Surveys zum Management von Ports und Broviacs in pädiatrisch-onkologischen Behandlungszentren

Klinische Padiatrie

Volumn 225, Issue 3, 2013, Pages 145-151

  Simon, Arne ^a   Graf, N ^a   Furtwangler R ^a  

^a Children's Hospital Medical Center   (Germany)

Author keywords

bloodstream infection; broviac; multicentre survey; paediatri oncology; port

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CARDIOVASCULAR CATHETER; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CHILD; CHILD HEALTH CARE; CHILDHOOD CANCER; CLINICAL PRACTICE; DISEASE ASSOCIATION; GERMANY; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PHYSICIAN; TREATMENT PLANNING;

ADOLESCENT; ANTINEOPLASTIC AGENTS; AUSTRIA; BACTEREMIA; BONE MARROW TRANSPLANTATION; CANCER CARE FACILITIES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHILD; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DISINFECTION; GERMANY; HEALTH SURVEYS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INDUCTION CHEMOTHERAPY; INSERVICE TRAINING; MANIKINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; SWITZERLAND; UTILIZATION REVIEW;

EID: 84878409557     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0033-1333762     Document Type: Article

References (55)

1. Adams D., Karpanen T., Worthington T. et al. Infection risk associated with a closed luer access device. J Hosp Infect: 2006; 62 353 357 (Pubitemid 43192329)
2. Austin P. D., Elia M. A systematic review and meta-analysis of the risk of microbial contamination of aseptically prepared doses in different environments. J Pharm Pharm Sci: 2009; 12 233 242
3. Beutel K., Simon A. Diagnostic and management of central venous line infections in pediatric cancer patients. Klin Padiatr: 2005; 217 91 100
4. Biwersi C., Hepping N., Bode U. et al. Bloodstream infections in a German paediatric oncology unit: Prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health: 2009; 212 541 546
5. Broviac J. W., Cole J. J., Scribner B. H. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet: 1973; 136 602 606
6. Btaiche I. F., Kovacevich D. S., Khalidi N. et al. The effects of needleless connectors on catheter-related bloodstream infections. Am J Infect Control: 2011; 39 277 283
7. Cecinati V., Brescia L., Tagliaferri L. et al. Catheter-related infections in pediatric patients with cancer. Eur J Clin Microbiol lnfect Dis: 2012; 31 2869 2877
8. Cesaro S., Corro R., Pelosin A. et al. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol: 2004; 83 183 188 (Pubitemid 38292240)
9. Crnich C. J., Halfmann J. A., Crone W. C. et al. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol: 2005; 26 708 714 (Pubitemid 41169741)
10. Del Pozo J. L., Garcia Cenoz M., Hernaez S. et al. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. Int J Antimicrob Agents: 2009; 34 482 485
11. Dettenkofer M., Jonas D., Wiechmann C. et al. Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravascular catheters. Infection: 2002; 30 282 285
12. Dissemond J., Assadian O., Gerber V. et al. Classification of wounds at risk and their antimicrobial treatment with polihexanide: a practice-oriented expert recommendation. Skin Pharmacol Physiol: 2011; 24 245 255
13. Dumichen M. J., Seeger K., Lode H. N. et al. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. J Hosp Infect: 2012; 80 304 309
14. Fratino G., Molinari A. C., Parodi S. et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol: 2005; 16 648 654 (Pubitemid 40613333)
15. Gapany C., Tercier S., Diezi M. et al. Frequent accesses to totally implanted vascular ports in pediatric oncology patients are associated with higher infection rates. J Vasc Access: 2011; 12 207 210
16. Gemeinsame Bundesausschuss nach § 91 Abs. 7 SGB V. Vereinbarung des Gemeinsamen Bundesausschusses über Maßnahmen zur Qualitä tssicherung für die stationäre Versorgung von Kindern und Jugendlichen mit hämato-onkologischen Krankheiten gemäß § 137 Abs. 1 Satz 3 Nr. 2 SGB V für nach § 108 SGB V zugelassene Krankenhäuser (Vereinbarung zur Kinderonkologie) vom 16. Mai 2006, geändert am 19. Dezember 2006 (Anlage 1), Inkrafttreten am 01. Januar 2007. Bundesanzeiger 2006; Nr. 129 vom 13. Juli 2006: 4997
17. Gonzalez G., Davidoff A. M., Howard S. C. et al. Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children. Pediatr Blood Cancer: 2012; 58 498 502
18. Grol R., Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet: 2003; 362 1225 1230 (Pubitemid 37255352)
19. Groll A. H., Attarbaschi A., Schuster F. R. et al. Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey. J Antimicrob Chemother: 2006; 57 527 535 (Pubitemid 43245429)
20. Haase R., Lieser U., Kramm C. et al. Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis. Klin Padiatr: 2011; 223 142 146
21. Handrup M. M., Fuursted K., Funch P. et al. Biofilm formation in longterm central venous catheters in children with cancer: a randomized controlled openlabelled trial of taurolidine versus heparin. Apmis: 2012; 120 794 801
22. Handrup M. M., Moller J. K., Frydenberg M. et al. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer: 2010; 55 309 313
23. Hickman R. O., Buckner C. D., Clift R. A. et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet: 1979; 148 871 875 (Pubitemid 9190337)
24. Horvath B., Norville R., Lee D. et al. Reducing central venous catheter-related bloodstream infections in children with cancer. Oncol Nurs Forum: 2009; 36 232 238
25. Hubner N. O., Siebert J., Kramer A. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacal Physiol: 2010; 23 244 258
26. Junqueira B. L., Connolly B., Abla O. et al. Severe neutropenia at time of port insertion is not a risk factor for catheter-associated infections in children with acute lymphoblastic leukemia. Cancer: 2010; 116 4368 4375
27. Keeney S., Hasson F., McKenna H. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs: 2006; 53 205 212 (Pubitemid 43455545)
28. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI) Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten - Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI). Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz: 2010; 53 357 388
29. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert KochInstitut Berlin Personelle und organisatorische Voraussetzungen zur Prävention nosokomialer Infektionen - Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz: 2009; 53 951 962
30. Krenn T., Fleischhack G., Moser O. et al. Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitals. Klin Padiatr: 2011; 223 335 340
31. Kuo Y. S., Schwartz B., Santiago J. et al. How often should a port-A-cath be flushed? Cancer Invest: 2005; 23 582 585 (Pubitemid 43286658)
32. Mermel L. A., Allon M., Bouza E. et al. Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis: 2009; 49 1 45
33. Niederhuber J. E., Ensminger W., Gyves J. W. et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery: 1982; 92 706 712 (Pubitemid 13091564)
34. Nowak-Gottl U., Ahlke E., Fleischhack G. et al. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood: 2003; 101 2529 2533 (Pubitemid 36857608)
35. O'Grady N. P., Alexander M., Burns L. A. et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control: 2011; 39 S1 S34
36. Phillips B., Selwood K., Lane S. et al. Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres. Arch Dis Child: 2007; 92 495 498 (Pubitemid 46867264)
37. Scheinemann K., Ethier M. C., Dupuis L. L. et al. Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer: 2010; 18 913 919
38. Secola R., Lewis M. A., Pike N. et al. "Targeting to zeroo" in pediatric oncology: a review of central venous catheter-related bloodstream infections. J Pediatr Oncol Nurs: 2012; 29 14 27
39. Simon A., Ammann R. A., Bode U. et al. Nosocomial infections in pediatric cancer patients: results of a prospective surveillance study from 7 University hospitals in Germany and Switzerland. BMC Infect Dis: 2008; E-Pub May 23, 2008: 70
40. Simon A., Ammann R. A., Wiszniewsky G. et al. Taurolidine-citrate lock solution (TauroLock™) significantly reduces CVAD-associated Gram positive infections in paediatric cancer patients. BMC Infectious Diseases: 2008; 8 102
41. rd Edition ed. Bonn: 2008
42. Simon A., Bode U., Beutel K. Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol lnfect: 2006; 12 606 620 (Pubitemid 43842480)
43. Simon A., Fleischhack G., Hasan C. et al. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol: 2000; 21 592 596
44. Simon A., Fleischhack G., Wiszniewsky G. et al. Influence of prolonged use of intravenous administration sets in paediatric cancer patients on cvad-related bloodstream infection rates and hospital resources. Infection: 2006; 34 258 263 (Pubitemid 44563983)
45. Simon A., Lehrnbecher T., Bode U. et al. Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey. Eur J Clin Microbiol lnfect Dis: 2007; 26 801 806 (Pubitemid 47573389)
46. Simon A., Sofka K., Wiszniewsky G. et al. Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology. Support Care Cancer: 2006; 14 91 97 (Pubitemid 43119603)
47. Simon A., Trautmann M. Needleless connection valves - commentary from a clinical perspective. Dtsch Med Wochenschr: 2008; 133 206 208 (Pubitemid 351268421)
48. Soothill J. S., Bravery K., Ho A. et al. A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: a pediatric single center before/after study on a hemopoietic stem cell transplant ward. Am J Infect Control: 2009; 37 626 630
49. Stucki C., Sautter A. M., Favet J. et al. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality. Am J Health Syst Pharm: 2009; 66 2032 2036
50. Tietz A., Frei R., Dangel M. et al. Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients. Infect Control Hosp Epidemiol: 2005; 26 703 707 (Pubitemid 41169740)
51. Toscano C. M., Bell M., Zukerman C. et al. Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care. Am J Infect Control: 2009; 37 327 334
52. Tschiedel E., Steinmann J., Buer J. et al. Results and relevance of molecular detection of pathogens by SeptiFast - a retrospective analysis in 75 critically ill children. Klin Padiatr: 2012; 224 12 16
53. Vescia S., Baumgartner A. K., Jacobs V. R. et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol: 2008; 19 9 15
54. Vonberg R. P., Gastmeier P. Hospital-acquired infections related to contaminated substances. J Hosp Infect: 2007; 65 15 23 (Pubitemid 44932975)
55. Wolf J., Shenep J. L., Clifford V. et al. Ethanol lock therapy in pediatric hematology and oncology. Pediatr Blood Cancer: 2013; 60 18 25